Meeting report: 31st International Conference on Antiviral Research

International Society for Antiviral Research

doi:10.1016/j.antiviral.2018.08.002

Meeting report: 31^st International Conference on Antiviral Research

International Society for Antiviral Research

Microbiology & Immunology

Upstate Medical University

Chevy Chase
KU Leuven
Autonomous University of Barcelona
Evotec
Cancer Research Center of Lyon
Drake University
Czech Academy of Sciences
Utrecht University
Utah State University

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

The 31^st International Conference on Antiviral Research (ICAR) was held in Porto, Portugal from June 11–15, 2018. In this report, volunteer rapporteurs provide their summaries of scientific presentations, hoping to effectively convey the speakers’ goals and the results and conclusions of their talks. This report provides an overview of the invited keynote and award lectures and highlights of short oral presentations, from the perspective of experts in antiviral research. Of note, a session on human cytomegalovirus included an update on the introduction to the clinic of letermovir for the prevention of CMV infection and disease. The 31^st ICAR successfully promoted new discoveries in antiviral research and drug development. The 32^nd ICAR will be held in Baltimore, Maryland, USA, May 6–10, 2019.

Original language	English
Pages (from-to)	88-102
Number of pages	15
Journal	Antiviral Research
Volume	158
DOIs	https://doi.org/10.1016/j.antiviral.2018.08.002
State	Published - Oct 2018

Access to Document

10.1016/j.antiviral.2018.08.002

Cite this

@article{b2b0d19d84ff402683d9de3a8af5fa1f,

title = "Meeting report: 31st International Conference on Antiviral Research",

abstract = "The 31st International Conference on Antiviral Research (ICAR) was held in Porto, Portugal from June 11–15, 2018. In this report, volunteer rapporteurs provide their summaries of scientific presentations, hoping to effectively convey the speakers{\textquoteright} goals and the results and conclusions of their talks. This report provides an overview of the invited keynote and award lectures and highlights of short oral presentations, from the perspective of experts in antiviral research. Of note, a session on human cytomegalovirus included an update on the introduction to the clinic of letermovir for the prevention of CMV infection and disease. The 31st ICAR successfully promoted new discoveries in antiviral research and drug development. The 32nd ICAR will be held in Baltimore, Maryland, USA, May 6–10, 2019.",

author = "\{International Society for Antiviral Research\} and Mike Bray and Graciela Andrei and Ester Ballana and Kara Carter and David Durantel and Brian Gentry and Zlatko Janeba and Jennifer Moffat and Oomen, \{Clasien J.\} and Bart Tarbet and Eva Riveira-Mu{\~n}oz and Est{\'e}, \{Jos{\'e} A.\}",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier B.V.",

year = "2018",

month = oct,

doi = "10.1016/j.antiviral.2018.08.002",

language = "English",

volume = "158",

pages = "88--102",

journal = "Antiviral Research",

issn = "0166-3542",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Meeting report

T2 - 31st International Conference on Antiviral Research

AU - International Society for Antiviral Research

AU - Bray, Mike

AU - Andrei, Graciela

AU - Ballana, Ester

AU - Carter, Kara

AU - Durantel, David

AU - Gentry, Brian

AU - Janeba, Zlatko

AU - Moffat, Jennifer

AU - Oomen, Clasien J.

AU - Tarbet, Bart

AU - Riveira-Muñoz, Eva

AU - Esté, José A.

PY - 2018/10

Y1 - 2018/10

N2 - The 31st International Conference on Antiviral Research (ICAR) was held in Porto, Portugal from June 11–15, 2018. In this report, volunteer rapporteurs provide their summaries of scientific presentations, hoping to effectively convey the speakers’ goals and the results and conclusions of their talks. This report provides an overview of the invited keynote and award lectures and highlights of short oral presentations, from the perspective of experts in antiviral research. Of note, a session on human cytomegalovirus included an update on the introduction to the clinic of letermovir for the prevention of CMV infection and disease. The 31st ICAR successfully promoted new discoveries in antiviral research and drug development. The 32nd ICAR will be held in Baltimore, Maryland, USA, May 6–10, 2019.

AB - The 31st International Conference on Antiviral Research (ICAR) was held in Porto, Portugal from June 11–15, 2018. In this report, volunteer rapporteurs provide their summaries of scientific presentations, hoping to effectively convey the speakers’ goals and the results and conclusions of their talks. This report provides an overview of the invited keynote and award lectures and highlights of short oral presentations, from the perspective of experts in antiviral research. Of note, a session on human cytomegalovirus included an update on the introduction to the clinic of letermovir for the prevention of CMV infection and disease. The 31st ICAR successfully promoted new discoveries in antiviral research and drug development. The 32nd ICAR will be held in Baltimore, Maryland, USA, May 6–10, 2019.

UR - https://www.scopus.com/pages/publications/85051407215

U2 - 10.1016/j.antiviral.2018.08.002

DO - 10.1016/j.antiviral.2018.08.002

M3 - Article

C2 - 30086336

SN - 0166-3542

VL - 158

SP - 88

EP - 102

JO - Antiviral Research

JF - Antiviral Research

ER -

Meeting report: 31^st International Conference on Antiviral Research

Abstract

Access to Document

Other files and links

Fingerprint

Cite this